These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 7618303

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Diagnostic significance of reduced serum caeruloplasmin concentration in neurological disease.
    Walshe JM.
    Mov Disord; 2005 Dec; 20(12):1658-61. PubMed ID: 16092117
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Molecular defect of ceruloplasmin synthesis and maturation in Wilson-Konovalov disease].
    Puchkova LV, Vakharlovskiĭ VG, Gaĭtskhoki VS, Monakhov NK, Shvartsman AL.
    Genetika; 1982 May; 18(5):703-12. PubMed ID: 7201432
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Serum nitric oxide levels in children with Wilson's disease.
    Selimoglu MA, Ertekin V, Turkan Y, Akcay F.
    Int J Clin Pract; 2007 Sep; 61(9):1530-4. PubMed ID: 17535304
    [Abstract] [Full Text] [Related]

  • 11. [Effect of ceruloplasmin conformation on its activity: significance for clinical analysis].
    Taras'ev MIu, Saburenkova EP, Dantsig II, Moshkov KA, Ryl'kov VV.
    Vopr Med Khim; 1991 Sep; 37(5):43-6. PubMed ID: 1661974
    [Abstract] [Full Text] [Related]

  • 12. [Immunoenzyme determination of the total level of ceruloplasmin in the serum from patients with hepatocerebral dystrophy].
    Saenko EL, Skorobagat'ko OV, Iaropolov AI.
    Biokhimiia; 1991 Sep; 56(9):1640-6. PubMed ID: 1747426
    [Abstract] [Full Text] [Related]

  • 13. [Phenocopy of hepatocerebral dystrophy (Wilson-Konovalov disease)].
    Makarova VA.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981 Sep; 81(11):1606-12. PubMed ID: 7324659
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Therapy of Wilson disease].
    Smolarek C, Stremmel W.
    Z Gastroenterol; 1999 Apr; 37(4):293-300. PubMed ID: 10378366
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The protective effect of normal and pathological (Wilson disease) ceruloplasmins on human erythrocytes.
    Saenko EL, Skorobogat'ko OV, Yaropolov AI.
    Biochem Int; 1990 Apr; 20(3):463-9. PubMed ID: 2161227
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Factors influencing serum ceruloplasmin levels in normal individuals.
    Cox DW.
    J Lab Clin Med; 1966 Dec; 68(6):893-904. PubMed ID: 5926186
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.